<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Credible</title>
	<atom:link href="http://www.tapanray.in/tag/credible/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Rewriting Pharma Strategy For ‘Doctor Google’ Era</title>
		<link>http://www.tapanray.in/rewriting-pharma-strategy-for-doctor-google-era/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=rewriting-pharma-strategy-for-doctor-google-era</link>
		<comments>http://www.tapanray.in/rewriting-pharma-strategy-for-doctor-google-era/#comments</comments>
		<pubDate>Mon, 17 Dec 2018 00:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[checker]]></category>
		<category><![CDATA[Credible]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[cybespace]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[online]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[platform]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[rewriting]]></category>
		<category><![CDATA[solution]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[symptom]]></category>
		<category><![CDATA[Syndrome]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[touchpoint]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[unique]]></category>
		<category><![CDATA[UPQ]]></category>
		<category><![CDATA[voluminous]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9316</guid>
		<description><![CDATA[In search of more and more information on an ailment, a large number of Internet savvy individuals now feel comfortable to consult ‘Doctor Google’ – much before approaching a qualified medical professional for the same. If and when they visit &#8230; <a href="http://www.tapanray.in/rewriting-pharma-strategy-for-doctor-google-era/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/rewriting-pharma-strategy-for-doctor-google-era/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Importance of Managing ‘Perception’ in Pharma</title>
		<link>http://www.tapanray.in/the-importance-of-managing-perception-in-pharma/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-importance-of-managing-perception-in-pharma</link>
		<comments>http://www.tapanray.in/the-importance-of-managing-perception-in-pharma/#comments</comments>
		<pubDate>Mon, 27 Aug 2018 00:00:35 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aushadhi]]></category>
		<category><![CDATA[constructive]]></category>
		<category><![CDATA[Credible]]></category>
		<category><![CDATA[destructive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[insiders]]></category>
		<category><![CDATA[Jan]]></category>
		<category><![CDATA[Managing]]></category>
		<category><![CDATA[negative]]></category>
		<category><![CDATA[outsiders]]></category>
		<category><![CDATA[perception]]></category>
		<category><![CDATA[positive]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reputation]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9117</guid>
		<description><![CDATA[Each one of us – individually or collectively in a society, community or even as a supporter of anyone or anything, view certain things in a certain way, and tend to believe only this is true. This process consequently leads &#8230; <a href="http://www.tapanray.in/the-importance-of-managing-perception-in-pharma/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-importance-of-managing-perception-in-pharma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Credible role of CCI and NPPA should allay fear of possible ill effects of FDI in Pharmaceuticals</title>
		<link>http://www.tapanray.in/credible-role-of-cci-and-nppa-should-allay-fear-of-possible-ill-effects-of-fdi-in-pharmaceuticals/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=credible-role-of-cci-and-nppa-should-allay-fear-of-possible-ill-effects-of-fdi-in-pharmaceuticals</link>
		<comments>http://www.tapanray.in/credible-role-of-cci-and-nppa-should-allay-fear-of-possible-ill-effects-of-fdi-in-pharmaceuticals/#comments</comments>
		<pubDate>Sun, 07 Aug 2011 23:30:32 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[allay]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[CCI]]></category>
		<category><![CDATA[commission]]></category>
		<category><![CDATA[competition]]></category>
		<category><![CDATA[Credible]]></category>
		<category><![CDATA[direct]]></category>
		<category><![CDATA[effects]]></category>
		<category><![CDATA[FDI]]></category>
		<category><![CDATA[fear]]></category>
		<category><![CDATA[foreign]]></category>
		<category><![CDATA[ill]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Possible]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=218</guid>
		<description><![CDATA[On August 3, 2011, ‘The Hindu Business Line’ reported, “Domestic drug-makers worried by side-effects of MNC buyouts.” It opined, “Acquisitions in the pharma industry came in for sharp focus, after several domestic drug-makers sold their operations partially or entirely to &#8230; <a href="http://www.tapanray.in/credible-role-of-cci-and-nppa-should-allay-fear-of-possible-ill-effects-of-fdi-in-pharmaceuticals/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/credible-role-of-cci-and-nppa-should-allay-fear-of-possible-ill-effects-of-fdi-in-pharmaceuticals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
